Name: UMIN ID:
Unique ID issued by UMIN | UMIN000024311 |
---|---|
Receipt number | R000028001 |
Scientific Title | Clarithromycin plus intravenous immunoglobulin therapy for Kawasaki disease, a phase 3, multicenter, randomized, double blind, placebo control study. |
Date of disclosure of the study information | 2016/10/06 |
Last modified on | 2019/04/09 10:15:57 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/10/06 10:23:43 | ||
2 | Update | 2016/10/06 14:36:35 | UMIN ID1 |
|
3 | Update | 2016/10/06 14:37:33 | UMIN ID2 |
|
4 | Update | 2016/12/14 14:06:17 | Recruitment status Anticipated trial start date |
|
5 | Update | 2016/12/14 14:07:28 | Interventions/Control_1 Interventions/Control_2 |
|
6 | Update | 2018/12/04 15:27:19 | Recruitment status |
|
7 | Update | 2019/04/09 10:10:37 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
8 | Update | 2019/04/09 10:11:32 | Number of participants that the trial has enrolled |
|
9 | Update | 2019/04/09 10:15:57 | Recruitment status Date of IRB Last follow-up date |